Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease Severity Among Adults in an Integrated Healthcare System in California
Kelly C. Young‐Wolff, Natalie E. Slama, Stacey E. Alexeeff, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 2, pp. 211-220
Open Access | Times Cited: 25

Showing 25 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 71
SARS-CoV-2 seroprevalence and associated risk factors in adult outpatients from Western Romania, January to March 2023: a seroepidemiological assessment after three years of COVID-19 pandemic
Tudor Rareș Olariu, Sorin Ursoniu, Alina Cristiana Craciun, et al.
Infectious Diseases (2025), pp. 1-11
Open Access | Times Cited: 2
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research
Neal L. Benowitz, Maciej Ł. Goniewicz, Bonnie Halpern‐Felsher, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 9, pp. 900-915
Open Access | Times Cited: 61
Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study
Hang Shang, Tianying Chang, Wei Yang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Risk of Repeated Adverse Effects following Booster Dose of mRNA COVID-19 Vaccine: Results from the MOSAICO Study
Pietro Ferrara, D. Ponticelli, Lorenzo Losa, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 247-247
Open Access | Times Cited: 11
Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study
Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 6, pp. 1184-1193
Open Access | Times Cited: 13
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study
Pietro Ferrara, D. Ponticelli, Roberto Magliuolo, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1353-1353
Open Access | Times Cited: 11
Current tobacco smoking and risk of SARS-CoV-2 infection and hospitalization: Evaluating the role of socio-demographic factors and comorbidities
Kelly C. Young‐Wolff, Natalie E. Slama, Lori C. Sakoda, et al.
Preventive Medicine (2023) Vol. 172, pp. 107523-107523
Open Access | Times Cited: 4
The Impact of the COVID-19 Pandemic on Nicotine Use: What Have We Learned?
Jessica L. Barrington‐Trimis, Elias M. Klemperer, Anuja Majmundar, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 2, pp. 175-176
Open Access | Times Cited: 7
COVID‐19 and tobacco products use among US adults, 2021 National Health Interview Survey
Mohammad Ebrahimi Kalan, Rime Jebai, Wei Li, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 4
Beyond SARS-CoV-2: epidemiological surveillance of respiratory viruses in Jalisco, Mexico
Isaac Murisi Pedroza‐Uribe, Natali Vega‐Magaña, José Francisco Muñoz‐Valle, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 1
Exploring the Relationship of Comorbidities, Smoking Status, HRCT Findings With COVID-19 Disease Severity and Outcomes
Sohail Khan Raja, Rubina Rafique Shiekh, Mohammad Ali Arshad Abbasi, et al.
Cureus (2024)
Open Access | Times Cited: 1
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
Christian Janke, Raquel Rubio‐Acero, Maximilian Weigert, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1556-1556
Open Access | Times Cited: 1
Systematic review and meta analysis of cross immunity and the smokers paradox in COVID19
Jesús González-Rubio, Juan D. Navarro‐López, Lydia Jiménez‐Díaz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Factors associated with SARS-COV-2 positive test in Lifelines
Grigory Sidorenkov, Judith M. Vonk, Marco Grzegorczyk, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294556-e0294556
Open Access | Times Cited: 2
Does misclassification of former tobacco smokers explain the ‘smoker’s paradox’ in the risk of COVID-19? Insights from the Stockholm Public Health Cohort
Ahmed Nabil Shaaban, Filip Andersson, Cecilia Magnusson, et al.
Scandinavian Journal of Public Health (2023) Vol. 51, Iss. 5, pp. 735-743
Open Access | Times Cited: 1
COVID-19 Vaccine Hesitancy by Smoking Status Among Ohio Adults
Prashant Bhandari, Andreas A. Teferra, Michael Nau, et al.
Ohio Journal of Public Health (2024) Vol. 6, Iss. 1, pp. 1-8
Open Access
Cross-Immunity as a Potential Explanation for the Smoker's Paradox in COVID-19: Evidence from a Systematic Review and Meta-Analysis
Jesús González-Rubio, Juan D. Navarro‐López, Lydia Jiménez‐Díaz, et al.
Research Square (Research Square) (2024)
Open Access
Immunological Insights: A Multicenter Longitudinal Study on Humoral Response to COVID-19 Vaccines in Greece
Eleni Makrì, Ekatherina Charvalos, Elisavet Stavropoulou, et al.
Deleted Journal (2024) Vol. 69, Iss. 2, pp. 101-113
Open Access
COVID-19 Disease and Chronic Health Outcomes Associated with Nicotine Use in a Great Plains Tribal Community: A Community-Based Study
Anna Tillery sup sup, Rae O’Leary, Angela Aherrera, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access
Cigarette smoking status and COVID-19 hospitalization in the context of cannabis use: An electronic health record cohort study in northern California
Dian Gu, Patrick K. Ha, Jesse T. Kaye, et al.
Addictive Behaviors Reports (2024) Vol. 20, pp. 100565-100565
Open Access
Lymphoma with skin localization and COVID 19 – a clinical case and review of literature
Maria Moneva-Sakelarieva, Yozlem Kobakova, Spiro Konstantinov, et al.
Pharmacia (2024) Vol. 71, pp. 1-7
Open Access
Nicotine Use Disorders: Impact on Critical Illness and Therapeutic Strategies
Victoria Mroz, Zdravka Zafirova
(2024), pp. 79-94
Closed Access
Differences in Social Distancing May Not Explain the Decreased Likelihood of SARS-CoV-2 Infection in Smokers
Guillaume Airagnes, Joane Matta, Maria Melchior, et al.
Nicotine & Tobacco Research (2023) Vol. 25, Iss. 10, pp. 1698-1700
Open Access
FAKTOR RISIKO INFEKSI SEKUNDER BAKTERI DAN POLA SENSITIVITAS ANTIBIOTIK PADA PASIEN COVID-19 DI RUANG INTENSIF SALAH SATU RUMAH SAKIT TIPE A DI BANDUNG
Rejeki Tri Ratna, Lia Amalia, Sumardi Uun
Pharmacoscript (2023) Vol. 6, Iss. 2, pp. 176-192
Open Access
Page 1

Scroll to top